L2 - Self Sufficiency in Growth Flashcards
Describe the basic paradigm that all growth signalling conforms to
Extracellular growth factor binding to a receptor protein
Triggering an intracellular signalling cascade
Resulting in changes in metabolism/protein function/gene expression
What two main ways is singalling controlled
Phosphorylation
GTP binding
Describe signalling through phosphorylation
Using kinases and phosphatases to add or remove phosphate groups
Can turn on or off in both ways
Describe signalling through GTP binding
Protein is active when GTP is bound and is hydrolysed to turn the proteins off - regulated by GAPs and GEFs
Where are RTKs
In the plasma membrane
Describe how RTKs are activated
Free to move around in the plasma membrane - bump into each other and they dimerise
What does phosphorylation allow
Biding of other proteins
Describe the steps that must occur for Ras to become active
Ligand binding to the RTK Dimerisation and autophosphorylation Phosphorylation allows binding of adaptor proteins with SH2 domains (Grb2) Allows binding of Ras GEFs (SOS) Leads to activation of Ras
What technique was used to determine that Ras had two configurations
Xray crystalography
What determines the confirmational state of Ras
GNMP binding
What are the gatekeeper residues of Ras why are they called this?
Gly12 and Gln61
They allow/fascilitate the binding and hydrolysis of GTP
What is critical to the turning on/off of Ras
The shape change
Alows the interaction with downstream effectors
What is FRET
Fluorescent
Describe the principle that FRET works on
Emission/excitation phenomena
Excite protein A at wavelength x causing emssion at wavelength y
Wavelength y is the excitation wavelength for protein B which then causes the emission of light at wavelength z
This concept can only occur if both A and B are close to each other (within a few nanometers
Describe how Ras signalling may be investigated using FRET
Inject a Ras binding protein labelled with cyan FP and Ras labelled with YFP
When Ras signalling is on two proteins will be close (bound) and FRET will be observed
4 ways that self sufficiency in growth signals may arise
Autocrine signalliung
Ligand independent
GTPase siwtch-off failure
Constituitve downstream signalling
What is oncogene adiction
A consequence of self-sufficiency in cell signalling where cells become addicted to a signalling pathway
Mutation and selection drive
Genetic streamlining
Describe the concept of genetic streamlining
Whereby cells under a selection pressure may undergo epigenetic silencing of a single pathway
What is a concequence of genetic streamlining
One pathway becomes dominant and the signal strength goes up
This can be seen through increased expression of a component of the pathway - usually the receptor
What is the consequence of increased levels of the receptor
Cells require a greater signal strength since the number of receptors they express is increased
More receptors = more receptors must be occupied for 100% signal saturation
What is the implication on treamtment of oncogene addiction
For targetted therapies have to target the dominant pathway
There is no effect on targetting pathways that arent the domiannt one
Give an example of a gene that is observed in oncogene addiction
HER 2
Is an RTK which requires ligand mediated dimerisation and subsequent autophosphorylation
Upregulated in a subset of breast cancers - oncogenic addiction
What was the drug used to treat HEr2 OE breast cancer
Trastusamab
Another name for Trastusamab
Herceptin
What is a Kaplan Meirer Plot
Time against survival - of a patient or a model system
Describe the Kaplan Meirer plot for treating with herceptin
Cells with low and high levels of HER2 do quite well when treated with herceptin
Cells with intermediate levels dont respond so well
Paper from this lecture
Self suff in growth signals
Neuregulin-1-mediated autocrine signalling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers`
What are HKI2727 and lapaptinib
Specific inhibtors for the HER1 and HEr2 tyrosine kinase
They are UNABLE to distinguish between the two so inhibit them both eqaully
What is Erlotinib
Specific inhibotr of HER1
Describe the methods used in the Neuregulin-1-mediated autocrine signalling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers paper
Measure cell growth in 72 different cell lines with and without the various drugs (for HER2 kinase inhibition)
Cell growth was measured using a dye which was quantifiable
What did they initially see
Some failed to respond and others are incredibly sensitive
What is neruregulin 1
Ligand for Her1
In the journal paper how was cell growth measured
Using an assay whereby the strength of colour of the dye was dependent on the levels of cell growth
Why was their unexplained sensitivity in some of the cells
Becuase there were no mutations in either the EGF receptor or overexpression of HER2
30 cell lines dispayed unexplained sensitivity
What was the next step once the 30 cell lines with unexplained sensitivity had been identified
Put into 3 categories and measure cell viability against concentration of lapatinib
What were the three categories
Sensitive
Moderately sensitive
Refractory
Describe what was seen when plotting viability against the concentration of drug used
Viabile at low concentrations
Variability of where inhibition seen - could be as low as 0.1 um or as high as 10um
What was the next step in determining why some cells were incredibly sensitive and others not
Using immunoblotting to look at all signalling pathways
What were the results of looking at multiple signalling pathways
Found that in sensitive cells lots of pHER3 relative to the ammount of HER3
In cells that werent sensitive there were still high levels of HER3 but not the phosphorylated version